Not Another Option. A Must for Market Access!
 
This week's BioPharma Dive brought to you by
 
 
Reduce patient aquisition costs up to 50%
Hi there,
Transform Your Commercial Strategy with Direct-to-Patient Models
Our turn-key Direct-to-Patient (DTP) model amplifies your existing commercial strategy by delivering unprecedented patient reach and adherence rates.
Proven Results for Pharma Manufacturers:
  • 95% onboarding/conversion rates (vs. 50% industry average)
  • 90% adherence/refill rates (vs. 50% industry average)
  • 30-50% lower patient-acquisition costs
See How Leading Brands Achieved These Results
 
Download our latest article to get actionable insights, and earn how leading brands are transforming commercial success in 5 minutes.
 
 
Download Article
7045 College Boulevard, Suite 300, Overland Park, KS 66211 ​​​​​
© 2025 EVERSANA. All Rights Reserved.
 

 

Want to reach 108,000+ biopharma executives with your own message? Get the media kit or contact us directly at advertising@industrydive.com.

About this email: You are receiving this message as part of your complimentary newsletter subscription to BioPharma Dive. If you no longer wish to receive the daily newsletter, you can switch to a weekly subscription or unsubscribe. See our full privacy policy. BioPharma Dive is a product of TechTarget, Inc. and its subsidiaries, 275 Grove St. Newton, MA, 02466